Principal Investigator
Trent Wang
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240116
Clinical Trial Summary
A Phase IIb Study of Axatilimab in Combination with Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Transplant/cellular therapy
Contact Information
Phone Number
305-243-2647